Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia Barragán

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|July 31, 2009
Solid-phase synthesis and DNA binding studies of dichloroplatinum(ii) conjugates of dicarba analogues of octreotide as new anticancer drugsFlavia Barragán, Virtudes Moreno, Vicente Marchán
Dalton Transactions (Cambridge, England : 2003)|May 15, 2008
Covalent radii revisitedBeatriz Cordero, Verónica Gómez, Ana E Platero-Prats, et al.
Molecular Pharmaceutics|March 21, 2013
Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cellsAriadna Grau-Campistany, Anna Massaguer, Dolors Carrion-Salip, et al.
Journal of the American Chemical Society|July 30, 2011
Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complexFlavia Barragán, Paula López-Senín, Luca Salassa, et al.
Bioconjugate Chemistry|August 9, 2012
Somatostatin subtype-2 receptor-targeted metal-based anticancer complexesFlavia Barragán, Dolors Carrion-Salip, Irene Gómez-Pinto, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|July 31, 2009
Solid-phase synthesis and DNA binding studies of dichloroplatinum(ii) conjugates of dicarba analogues of octreotide as new anticancer drugsFlavia Barragán, Virtudes Moreno, Vicente Marchán
Dalton Transactions (Cambridge, England : 2003)|May 15, 2008
Covalent radii revisitedBeatriz Cordero, Verónica Gómez, Ana E Platero-Prats, et al.
Molecular Pharmaceutics|March 21, 2013
Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cellsAriadna Grau-Campistany, Anna Massaguer, Dolors Carrion-Salip, et al.
Journal of the American Chemical Society|July 30, 2011
Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complexFlavia Barragán, Paula López-Senín, Luca Salassa, et al.
Bioconjugate Chemistry|August 9, 2012
Somatostatin subtype-2 receptor-targeted metal-based anticancer complexesFlavia Barragán, Dolors Carrion-Salip, Irene Gómez-Pinto, et al.
Pageof 1